Xyosted 54436-0275
Generic: Testosterone Enanthate
Product NDC
54436-0275- Manufacturer
- Antares Pharma, Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- November 15, 2018
- Listing Expires
- December 31, 2027
- Application
- NDA209863
Active Ingredients
| Ingredient | Strength |
|---|---|
| Testosterone Enanthate | 75 mg/.5mL |
Drug Class
Androgen Receptor Agonists [MoA]Androgen [EPC]Androstanes [CS]
Packaging Options(3)
1 SYRINGE in 1 CARTON (54436-275-01) / .5 mL in 1 SYRINGE (54436-275-03)
4 SYRINGE in 1 CARTON (54436-275-04) / .5 mL in 1 SYRINGE (54436-275-02)
1 SYRINGE in 1 CARTON (54436-275-05) / .5 mL in 1 SYRINGE (54436-275-02)